Genialis

Boston, United States

Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform.

$13.0M raised

Mar 2023

Series A

Top Investors

redalpineFirst Star VenturesTaiwania Capital Management CorporationScaleX VenturesEASME

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Genialis raised?

Genialis has raised $13.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.

Who are Genialis's investors?

Genialis's investors include redalpine, First Star Ventures, Taiwania Capital Management Corporation, ScaleX Ventures, EASME.

Where is Genialis headquartered?

Genialis is headquartered in Boston, United States.

What does Genialis do?

Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform.

What stage is Genialis at?

Genialis is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 29, 2023.

MLA

"Genialis — Funding & Investors." VCBacked, March 29, 2023, https://www.vcbacked.co/company/genialis. Accessed June 3, 2026.

APA

VCBacked. (2023). Genialis — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/genialis

Wikipedia (cite web)

{{cite web |title=Genialis — Funding & Investors |url=https://www.vcbacked.co/company/genialis |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 29, 2023.